CLINICAL TRIAL ANNOUNCEMENT:

An Experimental, One-Time Gene Therapy for Parkinson’s Disease

If your response to Parkinson’s disease medications has become unpredictable or isn’t what it used to be, this clinical study may be an option that you should discuss with your doctor. The RESTORE-1 Clinical Study is evaluating an experimental, one-time gene therapy approach to see if it may help improve motor function.

Who may be eligible to participate:

• 40 to 75 years of age
• Diagnosed with Parkinson’s disease for at least four years
• Have noticed your motor symptoms are unpredictable despite medication

Additional study eligibility requirements and restrictions apply.

To learn more visit www.RESTORE1Study.com